Alpha 2.0
Login Register
» Authors » S Kilian

S Kilian

Explore the profile of S Kilian including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 136
Followers 0
Related Specialties
Psychiatry
Neurology
Psychology
Top 10 Co-Authors
L Asmal
R Emsley
B Chiliza
L Phahladira
S Du Plessis
F Scheffler
H K Luckhoff
R Smit
S Seedat
M R Olivier
Published In
Schizophr Res
Psychol Med
Psychiatry Res Neuroimaging
Arch Microbiol
Afr J Psychiatry (Johannesbg)
Affiliations
Soon will be listed here.
Recent Articles
1.
Sex versus gender associations with depressive symptom trajectories over 24 months in first-episode schizophrenia spectrum disorders
Luckhoff H, Del Re E, Smit R, Kilian S, Phahladira L, Emsley R, et al.
Schizophr Res . 2024 Nov; 274:450-456. PMID: 39515254
Background: Females with schizophrenia often experience more severe and persistent depressive symptoms than males, in particular during the acute phase of the illness. In contrast to sex (a biological distinction),...
2.
A qualitative study of coping strategies and resilience in the aftermath of childhood adversity in first-episode psychosis
Wambua G, Kilian S, Chiliza B
Early Interv Psychiatry . 2024 May; 19(1):e13551. PMID: 38764159
Aim: Exposure to adversity during childhood is associated with elevated risk for commonly occurring forms of psychopathology, especially psychotic disorders. Despite the noteworthy consequences associated with adverse childhood experiences, an...
3.
Gender role endorsement in first-episode schizophrenia spectrum disorders
Luckhoff H, Asmal L, Scheffler F, Du Plessis S, Buckle C, Chiliza B, et al.
Psychiatry Res . 2021 Mar; 299:113867. PMID: 33751988
Sex (a biological distinction) and gender (a social construct) are inter-related, but semi-independent measures. The aim of our research was to compare gender role endorsement between first-episode schizophrenia spectrum disorder...
4.
Cannabis use and hippocampal subfield volumes in males with a first episode of a schizophrenia spectrum disorder and healthy controls
Scheffler F, Du Plessis S, Asmal L, Kilian S, Phahladira L, Luckhoff H, et al.
Schizophr Res . 2021 Mar; 231:13-21. PMID: 33740561
Background: Both schizophrenia and cannabis use are associated with structural brain changes. The hippocampus is a region of particular interest due to its role in memory and select cognitive functions,...
5.
Fronto-limbic white matter fractional anisotropy and body mass index in first-episode schizophrenia spectrum disorder patients compared to healthy controls
Luckhoff H, Du Plessis S, Scheffler F, Phahladira L, Kilian S, Buckle C, et al.
Psychiatry Res Neuroimaging . 2020 Sep; 305:111173. PMID: 32896691
In this diffusion tensor imaging study, we explored the associations of body mass index (BMI) with white matter microstructure in first-episode schizophrenia spectrum disorder patients (n = 69) versus healthy...
6.
Hippocampal subfield volumes and change in body mass over 12 months of treatment in first-episode schizophrenia spectrum disorders
Luckhoff H, Du Plessis S, Kilian S, Asmal L, Scheffler F, Phahladira L, et al.
Psychiatry Res Neuroimaging . 2020 May; 300:111084. PMID: 32388386
In this study, we explored the relationship between baseline hippocampal subfield volumes and change in body mass over 12 months of treatment in 90 first-episode schizophrenia spectrum disorder patients (66...
7.
Relationship between changes in metabolic syndrome constituent components over 12 months of treatment and cognitive performance in first-episode schizophrenia
Luckhoff H, Kilian S, Olivier M, Phahladira L, Scheffler F, Du Plessis S, et al.
Metab Brain Dis . 2019 Jan; 34(2):469-476. PMID: 30604027
Few studies have investigated the longitudinal effects of treatment-emergent metabolic syndrome changes on cognitive performance in first-episode psychosis. The aim of the present study was to determine the associations between...
8.
Weight gain and metabolic change as predictors of symptom improvement in first-episode schizophrenia spectrum disorder patients treated over 12 months
Luckhoff H, Phahladira L, Scheffler F, Asmal L, Du Plessis S, Chiliza B, et al.
Schizophr Res . 2018 Dec; 206:171-176. PMID: 30503765
Background: Treatment-emergent weight gain is associated with antipsychotic efficacy in schizophrenia patients treated with clozapine and olanzapine. However, few studies have investigated this relationship in first-episode patients treated with other...
9.
Effects of cannabis use on body mass, fasting glucose and lipids during the first 12 months of treatment in schizophrenia spectrum disorders
Scheffler F, Kilian S, Chiliza B, Asmal L, Phahladira L, Du Plessis S, et al.
Schizophr Res . 2018 Mar; 199:90-95. PMID: 29519756
While acute cannabis use stimulates appetite, general population studies suggest that chronic use is associated with reduced risk of obesity and other cardiometabolic risk factors. In this study we investigated...
10.
Childhood adversity and cognitive function in schizophrenia spectrum disorders and healthy controls: evidence for an association between neglect and social cognition
Kilian S, Asmal L, Chiliza B, Olivier M, Phahladira L, Scheffler F, et al.
Psychol Med . 2017 Dec; 48(13):2186-2193. PMID: 29268811
Background: Childhood adversity is associated with cognitive impairments in schizophrenia. However, findings to date are inconsistent and little is known about the relationship between social cognition and childhood trauma. We...